PGEN (STOCKS)
Precigen, Inc. Common Stock
$4.163500
+0.003500 (+0.08%)
Prev close: $4.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Helen Sabzevari
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,475.88M
- Employees
- 25
- P/E (TTM)
- -2.98
- P/B (TTM)
- 70.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.07 | $-0.09 | +0.0150 | +17.65% |
|
Sep 2025 (Q3)
|
$-1.06 | $-0.10 | -0.9631 | -993.91% |
|
Jun 2025 (Q2)
|
$-0.09 | $-0.08 | -0.0057 | -6.76% |
|
Mar 2025 (Q1)
|
$-0.07 | $-0.08 | +0.0116 | +14.22% |
Financial Statements
| Revenues | $9.68M |
| Benefits Costs and Expenses | $260.32M |
| Costs And Expenses | $260.32M |
| Nonoperating Income/Loss | -$140.13M |
| Operating Expenses | $120.19M |
| Selling, General, and Administrative Expenses | $70.13M |
| Research and Development | $41.33M |
| Other Operating Expenses | $8.73M |
| Operating Income/Loss | -$110.51M |
| Income/Loss From Continuing Operations After Tax | -$250.64M |
| Income/Loss From Continuing Operations Before Tax | -$250.64M |
| Income Tax Expense/Benefit | $3.00K |
| Income Tax Expense/Benefit, Current | $3.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$250.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$250.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$429.64M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $179.00M |
| Preferred Stock Dividends And Other Adjustments | $179.00M |
| Basic Earnings Per Share | -$1.37 |
| Diluted Earnings Per Share | -$1.37 |
| Basic Average Shares | 312,980,562 |
| Diluted Average Shares | 312,980,562 |
| Assets | $155.51M |
| Current Assets | $115.24M |
| Cash | $100.37M |
| Other Current Assets | $14.87M |
| Noncurrent Assets | $40.27M |
| Fixed Assets | $13.76M |
| Intangible Assets | $3.18M |
| Other Non-current Assets | $23.33M |
| Liabilities | $134.59M |
| Current Liabilities | $37.31M |
| Accounts Payable | $11.99M |
| Wages | $10.20M |
| Other Current Liabilities | $15.12M |
| Noncurrent Liabilities | $97.29M |
| Long-term Debt | $93.17M |
| Other Non-current Liabilities | $4.11M |
| Equity | $20.91M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $20.91M |
| Temporary Equity | $0.00 |
| Liabilities And Equity | $155.51M |
| Net Cash Flow From Operating Activities | -$87.83M |
| Net Cash Flow From Operating Activities, Continuing | -$87.83M |
| Net Cash Flow From Investing Activities | -$1.54M |
| Net Cash Flow From Investing Activities, Continuing | -$1.54M |
| Net Cash Flow From Financing Activities | $90.05M |
| Net Cash Flow From Financing Activities, Continuing | $90.05M |
| Exchange Gains/Losses | $35.00K |
| Net Cash Flow | $717.00K |
| Net Cash Flow, Continuing | $682.00K |
| Comprehensive Income/Loss | -$250.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $179.00M |
| Comprehensive Income/Loss Attributable To Parent | -$429.65M |
| Other Comprehensive Income/Loss | -$5.00K |